Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6.253 INR | +0,58% | +5,23% | +7,85% |
Vakgebied
- verkoop van generieke geneesmiddelen (79,9%): merknaam of generieke geneesmiddelen op recept en OTC-geneesmiddelen;
- verkoop van actieve ingrediënten (15,7%). De groep levert ook farmaceutische diensten op maat;
- overige (4,4%): verkoop van generieke biofarmaceutische producten, ontwikkeling van moleculaire middelen, enz.
De netto-omzet is geografisch als volgt verdeeld: India (18,8%), de Verenigde Staten (45%), Rusland (9,9%) en overig (26,3%).
Aantal werknemers: 25 863
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Global Generics
86,9
%
| 179 170 | 83,6 % | 213 768 | 86,9 % | +19,31% |
Pharmaceutical Services and Active Ingredients
11,8
%
| 30 740 | 14,3 % | 29 069 | 11,8 % | -5,44% |
Others
1,2
%
| 2 870 | 1,3 % | 3 042 | 1,2 % | +5,99% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
43,4
%
| 80 564 | 37,6 % | 106 683 | 43,4 % | +32,42% |
Others
27,4
%
| 68 962 | 32,2 % | 67 469 | 27,4 % | -2,16% |
India
20,5
%
| 43 986 | 20,5 % | 50 499 | 20,5 % | +14,81% |
Russia
8,6
%
| 20 879 | 9,7 % | 21 228 | 8,6 % | +1,67% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 02-04-18 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 02-11-20 |
Chairman | 56 | 18-01-93 | |
Gunupati Prasad
CHM | Chairman | 63 | 08-04-86 |
B. Phanimitra
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-23 |
K. Randhir Singh
CMP | Compliance Officer | - | 17-03-22 |
Archana Bhaskar
IRO | Public Communications Contact | 57 | 01-06-17 |
Amith Agarwal
IRC | Investor Relations Contact | - | - |
Jayanth Sridhar
PRN | Corporate Officer/Principal | - | - |
Vivek Mittal
LAW | General Counsel | - | 01-05-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 08-04-86 |
Chairman | 56 | 18-01-93 | |
Kalpana Morparia
BRD | Director/Board Member | 73 | 05-06-07 |
Shikha Sharma
BRD | Director/Board Member | 64 | 31-01-19 |
Leo Puri
BRD | Director/Board Member | 63 | 25-10-18 |
Claudio Albrecht
BRD | Director/Board Member | - | 10-05-23 |
Sanjiv Mehta
BRD | Director/Board Member | 63 | 29/12 |
Director/Board Member | 64 | 07-01-22 | |
Alpna Seth
BRD | Director/Board Member | 60 | 19-09-23 |
Penny Wan
BRD | Director/Board Member | - | 28-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 166 874 039 | 152 715 641 ( 91,52 %) | 345 564 ( 0,2071 %) | 91,52 % |
Bedrijfsgegevens
Dr. Reddy's Laboratories Ltd.
Door No. 8-2-337 Road No. 3
500034, Hyderabad
+91 40 4900 2900
http://www.drreddys.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Aurigene Discovery Technologies Ltd.
Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. |
Biotechnology
|
Dr. Reddy's Laboratories SA
Dr. Reddy's Laboratories SA Pharmaceuticals: MajorHealth Technology Part of Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories SA is a Swiss company that develops, manufactures and sells pharmaceutical products. The private company is based in Basel, Switzerland. |
Pharmaceuticals: Major
|
Aurigene Pharmaceutical Services Ltd.
Aurigene Pharmaceutical Services Ltd. BiotechnologyHealth Technology Aurigene Pharmaceutical Services Ltd. is a contract research, development, and manufacturing organization. It offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development, and manufacturing for clinical phase I-III programs. The company is headquartered in Bangalore, India. |
Biotechnology
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,85% | 12,49 mld. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |
- Beurs
- Aandelen
- Koers DRREDDY
- Onderneming Dr. Reddy's Laboratories Limited